The PCPT trial

The PCPT trial

Show other versions (2)

The PCPT trial is the first phase III trial with the principal objective of examining the hypothesis that the use of chemoprevention could prevent the development of prostate cancer. This is a large scale randomised clinical trial comparing finasteride (5-α reductase inhibitor) to placebo. A total o...

Bibliografske podrobnosti
Main Authors:	Hamdy, F, Rouprêt, M
Format:	Journal article
Jezik:	French
Izdano:	2008

Podobne knjige/članki

[The PCPT trial].
od: Hamdy, F, et al.
Izdano: (2008)

The PCPT trial
od: Hamdy, F, et al.
Izdano: (2008)

Estimating Hydraulic Conductivity of Overconsolidated Soils Based on Piezocone Penetration Test (PCPT)
od: Binyam M. Bekele, et al.
Izdano: (2021-02-01)

In-situ determination of soil compressibility using piezometer cone penetration testing (PCPT)/
od: 207490 Ismail Bakar, et al.
Izdano: (1981)

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
od: Ankerst, D, et al.
Izdano: (2012)

In-situ determination of soil compressibility using piezometer cone penetration testing (PCPT) / [mikrofilem]
od: 207490 Ismail Bakar

A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort
od: Samuel Carbunaru, et al.
Izdano: (2019-11-01)

Time-dependent behavior of full-scale precast post-tensioned (PCPT) girders: Experimental and finite element analysis
od: Panuwat Joyklad, et al.
Izdano: (2022-12-01)

Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA
od: Enrique Gomez Gomez, et al.
Izdano: (2019-11-01)

Correction: Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA
Izdano: (2020-02-01)

Prostate cancer risk calculators – PBCG vs. PCPT 2.0: Which one should we use when it comes to clinical decision-making?
od: A.B. Silva, et al.
Izdano: (2020-11-01)

PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL
od: Christiano Tansol, et al.
Izdano: (2017-07-01)

Becoming editor-in-chief of European Urology Oncology: The 4 pillars of the development strategy
od: M. Rouprêt
Izdano: (2023-11-01)

Transurethral resection biopsy as part of a saturation biopsy protocol: a cohort study and review of the literature.
od: Yates, DR, et al.
Izdano: (2013)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
od: Rouprêt, M, et al.
Izdano: (2005)

The prostate cancer prevention trial and its messages.
od: Hamdy, F
Izdano: (2007)

Clinically localised prostate cancer is microsatellite stable.
od: Azzouzi, A, et al.
Izdano: (2007)

Word of wisdom. Re: mortality results from the Goteborg randomised population-based prostate-cancer screening trial.
od: Hamdy, F
Izdano: (2010)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
od: Rouprêt, M, et al.
Izdano: (2008)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
od: Roupret, M, et al.
Izdano: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
od: Roupret, M, et al.
Izdano: (2007)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
od: Hamdy, F, et al.
Izdano: (2003)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
od: Elisabeth Grobet-Jeandin, et al.
Izdano: (2021-10-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
od: Roupret, M, et al.
Izdano: (2004)

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
od: Rouprêt, M, et al.
Izdano: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
od: Roupret, M, et al.
Izdano: (2007)

Understanding and improving recruitment to randomised controlled trials: Qualitative research approaches.
od: Elliott, D, et al.
Izdano: (2017)

Robot-assisted laparoscopic artificial urinary sphincter insertion in women with stress urinary incontinence: A pilot single-center study
od: E. Chartier-Kastler, et al.
Izdano: (2020-07-01)

Addressing patient treatment preferences at trial recruitment.
od: Mills, N, et al.
Izdano: (2011)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
od: Lane, J, et al.
Izdano: (2009)

[Early diagnosis and surgical management of prostate cancer]
od: Linton, D, et al.
Izdano: (2004)

Early diagnosis and surgical management of prostate cancer
od: Linton, D, et al.
Izdano: (2004)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
od: Donovan, J, et al.
Izdano: (2003)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
od: Lane, J, et al.
Izdano: (2007)

Exploring treatment preferences facilitated recruitment to randomized controlled trials
od: Mills, N, et al.
Izdano: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials.
od: Mills, N, et al.
Izdano: (2011)

Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.
od: Mills, N, et al.
Izdano: (2003)

Clinical Trial Protocol for PERFECT: A Randomised Controlled Trial Comparing the Efficiency and Tolerance of Transperineal Fusion Versus Transrectal Imaging-targeted Prostate Biopsies (CCAFU-PR1 Study)
od: Alae Touzani, et al.
Izdano: (2022-11-01)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
od: Lane, J, et al.
Izdano: (2004)

In defense of randomized clinical trials in surgery: Let us not forget Archie Cochrane's legacy.
od: Catto, J, et al.
Izdano: (2017)